Brian Crawford
Director, Astellas Gene Therapy Communications at Audentes Therapeutics - San Francisco, California, US
Brian Crawford's Colleagues at Audentes Therapeutics
Tmirah Haselkorn
Senior Director of Global Evidence, Outcomes Research and Registries
Brian Crawford's Contact Details
(415) 818-1005
San Francisco Bay Area
Audentes Therapeutics
Brian Crawford's Company Details
Audentes Therapeutics is a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases. We are leveraging our AAV gene therapy technology platform and proprietary manufacturing expertise to develop programs across three modalities: gene replacement, vectorized exon skipping, and vectorized RNA knockdown. Our product candidates are showing promising therapeutic profiles in clinical and preclinical studies across a range of neuromuscular diseases. Audentes is a focused, experienced and passionate team driven by the goal of improving the lives of patients. If you are interested in learning more about our company, please do not hesitate to contact us.